Nav: Home

Soy may help protect women with PCOS from diabetes, heart disease

August 04, 2016

Washington, DC--Women who have polycystic ovary syndrome (PCOS)--a common cause of female infertility--may be able to improve their metabolic and cardiovascular health by consuming soy isoflavones, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Soy isoflavones are naturally occurring plant-based estrogens found in the soybean plant. They are found in foods such as soy milk, as well as supplements.

The study examined how a diet containing soy isoflavones could benefit women with PCOS--a condition that affects an estimated 5 million to 6 million women in the United States.

Among the most common hormone disorders in women of reproductive age, PCOS occurs when a women's body produces slightly higher amounts of testosterone and other androgen hormones--sex hormones typically associated with men, but also found in women--than normal. The resulting hormone imbalance can cause irregular or absent menstrual periods, infertility, weight gain, acne, excess hair on the face and body, or thinning hair on the scalp. Women who have PCOS also face a higher risk of developing other health problems, including diabetes and coronary heart disease.

"Our research found that women who have PCOS may benefit from incorporating soy isoflavones in their diets," said the study's first author, Zatollah Asemi, PhD, of Kashan University of Medical Sciences in Kashan, Iran. "In the first study to examine the connection, we found women who consumed soy isoflavones regularly saw improvement in biological markers that reflect how effectively the body utilizes insulin to process sugars and had reduced levels of harmful cholesterol."

Seventy women who were between the ages of 18 and 40 and had PCOS participated in the prospective randomized double-blind, placebo-controlled clinical trial. The women were referred to the Kosar Clinic in Arak, Iran, between December 2015 and February 2016.

Half of the women were randomly assigned to take a daily 50 mg/d soy isoflavone supplement daily for 12 weeks. This amount is equivalent to the amount of soy isoflavones in 500 milliliters of soy milk. The other 35 participants received a placebo. Participants were instructed to maintain current levels of exercise and to avoid taking other nutritional supplements during the study.

Blood samples were taken from the women at the beginning and end of the study. The blood samples were analyzed to measure hormone and lipid levels, as well as biomarkers of insulin resistance and inflammation.

In comparison to the placebo group, women who received soy isoflavones had lower levels of circulating insulin in the blood and other biological markers associated with insulin resistance--a condition where the body doesn't use insulin to process sugars effectively and that can lead to Type 2 diabetes. The researchers also found women who took soy isoflavone supplements tended to have lower levels of testosterone, harmful cholesterol known as LDL and triglycerides, or fats in the blood, than their counterparts who received the placebo.

"There is growing interest in how adding soy to the diet can help address metabolic syndrome and related health conditions," Asemi said. "Our findings indicate consuming soy isoflavone regularly may help women with PCOS improve their metabolic and cardiovascular health."
-end-
Asemi's co-author is Mehri Jamilian of Arak University of Medical Sciences in Arak, Iran.

The research was supported by a grant from the Vice-chancellor for Research, Kashan University of Medical Sciences and Arak University of Medical Sciences, as well as the government of Iran.

The study, "The Effects of Soy Isoflavones on Metabolic Status of Patients with Polycystic Ovary Syndrome," will be published online at http://press.endocrine.org/doi/10.1210/jc.2016-1762, ahead of print.

For more information on PCOS, explore the Hormone Health Network's digital toolkit.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society, which is celebrating its centennial in 2016, has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...